GlassScriptPhysician profile
William Harrigan
NPI 1770587529
$2,367.45
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,699 · 2020: $104 · 2021: $416 · 2022: $124 · 2024: $25.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $508.16 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $365.01 | 2019-2022 | |
| Amgen INC. | $220.97 | 2019 | |
| Lilly USA, LLC | $206.39 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.80 | 2019 | |
| Merck Sharp & Dohme LLC | $140.11 | 2019 | |
| Novo Nordisk INC | $128.67 | 2019-2020 | |
| Allergan, INC. | $102.43 | 2019-2021 | |
| Glaxosmithkline, LLC. | $99.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $73.53 | 2019 | |
| Pfizer INC. | $62.38 | 2019 | |
| Amarin Pharma, INC. | $50.56 | 2019 | |
| Astellas Pharma US INC | $50.42 | 2019 | |
| Genentech USA, INC. | $36.94 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $27.01 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.07 | 2024 | |
| Gilead Sciences, INC. | $23.64 | 2020 | |
| Daiichi Sankyo INC. | $22.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.71 | 2019 | |
| Nestle Healthcare Nutrition INC. | $15.68 | 2022 | |
| Sanofi Pasteur INC. | $15.25 | 2019 | |
| Shire North American Group INC | $12.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.